The effect of variable fat diets and cholesterol-lowering drugs on antithrombin III levels in hyperlipoproteinemic and normal subjects
- 1 June 1983
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 30 (6) , 661-669
- https://doi.org/10.1016/0049-3848(83)90275-x
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Increased in vivo and in vitro platelet function in type II- and type IV-hyperlipoproteinemiaThrombosis Research, 1979
- Antithrombin functional activity after saturated and unsaturated fatty meals and fasting in normal subjects and some disease statesThrombosis Research, 1979
- Fluorescent substrate assay for antithrombin IIIThrombosis Research, 1978
- A new two-stage functional assay for antithrombin-III (Heparin cofactor): Clinical and laboratory evaluationThrombosis Research, 1976
- Hyperlipidemia, hypercoagulability, and accelerated thrombosis: studies in congenitally hyperlipidemic rats and in rats and monkeys with induced hyperlipidemiaBlood, 1976
- Hereditary antithrombin iii deficiency and thromboembolic diseaseAmerican Journal of Hematology, 1976
- Actions and Interactions of Antithrombin and HeparinNew England Journal of Medicine, 1975
- Platelet Function in HyperlipoproteinemiaNew England Journal of Medicine, 1974
- Effect of feeding fat on fibrinolysis, Stypven time, and platelet aggregation in Africans, Asians, and EuropeansJournal of Clinical Pathology, 1970
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955